Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Proposal for savings on NHS drug bill rejected

Nicholas Timmins
Friday 25 March 1994 00:02 GMT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Virginia Bottomley has over-ruled her health minister Dr Brian Mawhinney and kicked out proposals to make it much easier for doctors to prescribe non-brand name drugs, writes Nicholas Timmins.

She has done so despite a report from the spending watchdog the Audit Commission this month which said a further switch to non-branded, or generic, drugs could save the NHS at least pounds 45m a year.

Her move follows intense pressure from the drug industry, which reacted with fury to Dr Mawhinney's announcement last month that he was keen to explore generic substitution - where pharmacists can replace a doctor's prescription for brand name drugs with cheaper generic ones.

Mrs Bottomley told a Financial Times conference that the Government had never been convinced that generic substitution was the solution.

The ABPI welcomed Mrs Bottomley's statement.

David Blunkett, Labour's health spokesman, accused her of showing more regard for 'her friends in the drug industry' than for patients.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in